During the past decade, Mc Haaglanden, Locatie Antoniushove; Interne Geneeskunde conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mc Haaglanden, Locatie Antoniushove; Interne Geneeskunde" are "Breast Neoplasms" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Mc Haaglanden, Locatie Antoniushove; Interne Geneeskunde" in a lesser frequency.

Most popular intervention types in "Mc Haaglanden, Locatie Antoniushove; Interne Geneeskunde" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (2 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials), "Docetaxel" (1 trials) and "Nab-paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mc Haaglanden, Locatie Antoniushove; Interne Geneeskunde" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mc Haaglanden, Locatie Antoniushove; Interne Geneeskunde". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mc Haaglanden, Locatie Antoniushove; Interne Geneeskunde, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mc Haaglanden, Locatie Antoniushove; Interne Geneeskunde, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".